Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 80Brain Neoplasms 34Gliosarcoma 30Glioma 24Astrocytoma 18Central Nervous System Neoplasms 11Medulloblastoma 9Oligodendroglioma 5Neuroblastoma 5Ganglioneuroblastoma 5Ependymoma 4Diffuse Intrinsic Pontine Glioma 4Neoplasms 3Breast Neoplasms 3Meningeal Carcinomatosis 2Melanoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Untreated Childhood Anaplastic Astrocytoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pinealoma 1

Interventions

Waiting Lists 1Streptozocin 1Radiosurgery 1Radiation 1Mercaptopurine 1Circulating Tumor DNA 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Radiation × CNS × Clear all
NCT00004659 2005-06-24

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Office of Rare Diseases (ORD)

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡